EUVIMEDEUVIMED entdecken
Open Access

Triptonide enhances DNA damage by inhibiting TRIP13‑mediated DNA repair and synergizes with bortezomib to suppress multiple myeloma

Fen He, Junjun Li, Lijun Peng, Hongyan Zhao, Maoyou Lu, Ruixin Gao, Siqi Wang, Yu Chen, Ruihan Tang, Zhengguo Li, Linlin Zhang, Xinyu Zhang und 6 weitere

International Journal of Oncology · 14.07.2026 · 69 (3) · 1-14

DOI: 10.3892/ijo.2026.5919 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Oncology, online erschienen am 14.07.2026. Verfasst von Fen He und 17 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Province Key Laboratory of Tumor Cellular and Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South Chin…. Hauptthemen laut MEDLINE: Multiple Myeloma, Bortezomib, DNA Damage, DNA Repair. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaBortezomibDNA DamageDNA RepairTriterpenesATPases Associated with Diverse Cellular ActivitiesAntineoplastic Combined Chemotherapy ProtocolsCell Cycle ProteinsHumansAnimalsDrug SynergismMiceApoptosisCell Line, TumorXenograft Model Antitumor AssaysCell ProliferationCell Survival

Stichwörter der Autor:innen

DNA damageTRIP13bortezomibmultiple myelomatriptonide

Substanzen

BortezomibTriterpenestriptonideATPases Associated with Diverse Cellular ActivitiesCell Cycle Proteins

Autor:innen und Institutionen

  • Hunan Province Key Laboratory of Tumor Cellular and Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China.
  • Department of Hematology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China.
  • Department of Spine Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China.

Zitieren

APA

He, F., Li, J., Peng, L., Zhao, H., Lu, M., Gao, R., Wang, S., Chen, Y., Tang, R., Li, Z., Zhang, L., Zhang, X., Li, Q., Chen, W., Liu, J., Luo, C., Zeng, X., & Xia, J. (2026). Triptonide enhances DNA damage by inhibiting TRIP13‑mediated DNA repair and synergizes with bortezomib to suppress multiple myeloma. International Journal of Oncology, 69(3), 1-14. https://doi.org/10.3892/ijo.2026.5919

Vancouver

He F, Li J, Peng L, Zhao H, Lu M, Gao R, et al. Triptonide enhances DNA damage by inhibiting TRIP13‑mediated DNA repair and synergizes with bortezomib to suppress multiple myeloma. International Journal of Oncology. 2026;69(3):1-14. doi:10.3892/ijo.2026.5919

BibTeX
@article{He2026,
  author = {He, Fen and Li, Junjun and Peng, Lijun and Zhao, Hongyan and Lu, Maoyou and Gao, Ruixin and Wang, Siqi and Chen, Yu and Tang, Ruihan and Li, Zhengguo and Zhang, Linlin and Zhang, Xinyu and Li, Qianhao and Chen, Weihui and Liu, Jiayu and Luo, Cong and Zeng, Xi and Xia, Jiliang},
  title = {Triptonide enhances DNA damage by inhibiting TRIP13‑mediated DNA repair and synergizes with bortezomib to suppress multiple myeloma},
  journal = {International Journal of Oncology},
  year = {2026},
  volume = {69},
  number = {3},
  pages = {1--14},
  doi = {10.3892/ijo.2026.5919}
}
Kostenlos starten →